Succimer
Succimer (DMSA, dimercaptosuccinic acid) is a water-soluble chelating agent used for the treatment of lead poisoning in children and adults, forming stable water-soluble complexes with heavy metals including lead, mercury, and arsenic that are excreted in urine. Unlike older chelators such as EDTA and BAL, succimer is orally bioavailable with lower toxicity and greater selectivity for lead over essential minerals. It is also used as a renal imaging agent (technetium-99m DMSA) for cortical scintigraphy.
Peso molecular
182,2000 g/mol
LogP
0,10
TPSA
76,60 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.
Estructura 2D
Cite this structure
Embed this structure
SMILES
O=C(O)[C@@H](S)[C@@H](S)C(=O)O
InChI
InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+
Molecular Formula
C4H6O4S2
HBD / HBA
4 / 6
Enlaces Rotables
3
Átomos Pesados
10
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
Succimer (DMSA, dimercaptosuccinic acid) is a water-soluble chelating agent used for the treatment of lead poisoning in children and adults, forming stable water-soluble complexes with heavy metals including lead, mercury, and arsenic that are excreted in urine. Unlike older chelators such as EDTA and BAL, succimer is orally bioavailable with lower toxicity and greater selectivity for lead over essential minerals. It is also used as a renal imaging agent (technetium-99m DMSA) for cortical scintigraphy.
Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.
Yes, Succimer is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201073. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2724354. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="succimer"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/succimer/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/succimer/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/succimer/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="succimer"></drugfyi-drug>